ESLA — Estrella Immunopharma Share News
0.000.00%
Last trade - 00:00Brief: Estrella Immunopharma Offers Up To 2.5 Mln Shares For Resale By Selling Stockholders
Brief: Estrella Advances Starlight-1 Trial Into Phase II Following Positive DSMB Recommendation
Brief: Estrella Immunopharma Regains Compliance With Nasdaq Listing Requirements
Brief: Estrella Immunopharma Announces Activation Of Additional Site For Phase I/Ii Starlight-1 Trial In B-Cell Non-Hodgkin’S Lymphoma
Brief: Estrella Immunopharma Initiates Second Cohort and Doses First Patient in STARLIGHT-1 Trial of EB103 in Advanced B-Cell Non-Hodgkin’s Lymphomas
Brief: Estrella Immunopharma Completes First Dose Cohort In Starlight-1 Trial And Receives Approval To Initiate Higher Dose Cohort
Brief: Estrella Immunopharma Inc - Regains Compliance With Nasdaq Minimum Bid Price Requirement
Brief: Estrella Immunopharma Entered Amendment No. 2 To Common Stock Purchase Agreement Dated April 20, 2023
Brief: Estrella Immunopharma Changes Fiscal Year End To December 31
Brief: Estrella Achieves Complete Response In First Patient Treated With CD19- Redirected Artemis T-Cells
Brief: Estrella Immunopharma Announces Appointment Of Hong Zhang As Chairperson And Board Member
Brief: Estrella Immunopharma Filed Certificate Of Ownership & Merger With Delaware Secretary Of State To Effect Merger With Estrella Biopharma
Brief: Estrella Immunopharma Entered Into Statement Of Work No. 001 With Eureka Therapeutics
Brief: Tradeup Acquisition Corp. And Estrella Biopharma, Inc. Announce Completion Of Business Combination
Brief: Tradeup Acquisition Says Entered Into A Binding Term Sheet With Suma Ventures And Others
Brief: TradeUP Acquisition Announces Extension Of The Deadline For An Initial Business Combination
Brief: Tradeup Acquisition Corp On June 22 Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
Brief: TradeUP Acquisition Corp Announces Extension Of Deadline For Initial Business Combination
Brief: Tradeup Acquisition Corp. Announces Extension Of The Deadline For An Initial Business Combination